Robin Steigerwald

Robin Steigerwald is an accomplished professional with extensive experience in vaccine development and virology. Currently serving as the Manager of Vaccine Development at Bavarian Nordic A/S since November 2003, Robin has held various roles within the company, including Virology Specialist and Senior Scientist, leading significant projects in vaccine research. Prior experience includes a position as a Scientist at the Max Planck Institute of Biochemistry, where Robin focused on telomerase regulation in cancer cells and supported PhD students, as well as a post-doctoral role at Roche Diagnostics involving the development of diagnostic antibodies for bladder carcinoma. Academic qualifications include a Dr. rer. nat. in Molecular Biology and Virology from the Max Planck Institute of Biochemistry and a Diploma in Biology with a focus on Genetics, Biochemistry, and Microbiology from the University of Regensburg.